RUNX1T1 and neoplasm: Importantly, we demonstrate that oncogenic AML1-ETO is a direct and novel target of miR-29b-1, providing a mechanistic link between AML1-ETO-mediated leukemogenic properties and tumor suppressor activities of miR-29b-1.